WHO Eliminates Remdesivir From List Of Medicines Used As Benchmark
Suspension is signal that WHO does not recommend countries procure the drug for COVID: Official
The World Health Organization stated on Friday it has actually suspended Gilead’s remdesivir from its so-called prequalification list, a main list of medicines utilized as a criteria for procurement by developing nations, after releasing guidance versus its use in hospitalised COVID-19 patients.
” Yes we have actually suspended it from the PQ (prequalification list),” Tarik Jasarevic stated in an emailed action to Reuters.
” The suspension is a signal to nations that WHO, in compliance with the treatment guidelines, does not recommend nations obtain the drug for COVID.”
He included that the WHO was not conscious that any worldwide procurers were providing the drug to low-and middle-income countries.
( Except for the headline, this story has actually not been modified by NDTV staff and is published from a syndicated feed.)
CLICK ON THIS LINK TO READ MORE
( the headline, this story has not been released by Crucial India News personnel and is published from a syndicated feed.).